Top Biotechnology & Medical Research stocks in Australia
Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.
Name | Market Cap | Price to Earnings TTM | Dividend Yield % TTM |
---|---|---|---|
AU$4.63bn | 211.5 | n/a | |
AU$2.83bn | n/a | n/a | |
AU$1.04bn | n/a | n/a | |
AU$715.44m | n/a | n/a | |
AU$335.89m | n/a | n/a | |
AU$308.23m | n/a | n/a | |
AU$297.31m | 20.1 | 1.12% | |
AU$279.73m | n/a | n/a | |
AU$200.82m | n/a | n/a | |
AU$114.09m | n/a | n/a | |
AU$105.15m | n/a | n/a | |
AU$104.97m | n/a | n/a | |
AU$99.84m | n/a | n/a | |
AU$86.59m | 17.54 | n/a | |
AU$85.78m | n/a | n/a | |
AU$69.65m | n/a | n/a | |
AU$64.01m | n/a | n/a | |
AU$62.36m | n/a | n/a | |
AU$62.22m | n/a | n/a | |
AU$61.94m | n/a | n/a |